glp 1 and binge eating disorder GLP-1 Receptor Agonists Research to Treat Overeating and Substance Use Disorders GLP-1 Therapy: An Emerging Tool

Their half-life ranges from 24 hours (short-acting agents such as exenatide, lixisenatide) to 57 days (long-acting agents such as liraglutide, dulaglutide, semaglutide)

In mice, bile acids can breach the BBB by activating the nuclear receptor farnesoid X receptor (FXR) in the ileum

Some individuals report headache or dizziness, though it is often unclear whether these symptoms are directly attributable to the supplement or coincidental

This finding established bacterially synthesized vitamin B 6 as an intrinsic antimicrobial agent, positioning it as a promising alternative to conventional antibiotics

Increasing the glomerular filtration rate may reduce circulating TMAO